Canada markets open in 7 hours 34 minutes

Deciphera Pharmaceuticals, Inc. (DCPH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
15.46-0.39 (-2.46%)
At close: 04:00PM EDT
15.36 -0.10 (-0.65%)
After hours: 07:11PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.06B
Enterprise Value 705.87M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)9.20
Price/Book (mrq)2.62
Enterprise Value/Revenue 6.47
Enterprise Value/EBITDA -2.76

Trading Information

Stock Price History

Beta (5Y Monthly) 1.10
52-Week Change 3-41.57%
S&P500 52-Week Change 3-2.99%
52 Week High 337.99
52 Week Low 36.51
50-Day Moving Average 313.56
200-Day Moving Average 310.88

Share Statistics

Avg Vol (3 month) 3956.06k
Avg Vol (10 day) 3981.72k
Shares Outstanding 566.82M
Implied Shares Outstanding 6N/A
Float 836.93M
% Held by Insiders 127.64%
% Held by Institutions 173.67%
Shares Short (Jul 28, 2022) 47.05M
Short Ratio (Jul 28, 2022) 49.46
Short % of Float (Jul 28, 2022) 416.27%
Short % of Shares Outstanding (Jul 28, 2022) 410.56%
Shares Short (prior month Jun 29, 2022) 47.17M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022


Profit Margin -236.57%
Operating Margin (ttm)-213.08%

Management Effectiveness

Return on Assets (ttm)-27.75%
Return on Equity (ttm)-60.63%

Income Statement

Revenue (ttm)109.14M
Revenue Per Share (ttm)1.72
Quarterly Revenue Growth (yoy)37.80%
Gross Profit (ttm)-141.62M
EBITDA -229.41M
Net Income Avi to Common (ttm)-258.19M
Diluted EPS (ttm)-4.90
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)383.85M
Total Cash Per Share (mrq)5.74
Total Debt (mrq)30.58M
Total Debt/Equity (mrq)7.55
Current Ratio (mrq)6.02
Book Value Per Share (mrq)6.06

Cash Flow Statement

Operating Cash Flow (ttm)-218.05M
Levered Free Cash Flow (ttm)-112.45M